[1]耿叶 孙林.CMR用于评估ACS患者PCI术后心功能改善的研究现状[J].心血管病学进展,2022,(12):1078.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.005]
 GENG YeSUN Lin.Research Status of CMR to Evaluate the Improvement of Cardiac Function in ACS Patients after PCI[J].Advances in Cardiovascular Diseases,2022,(12):1078.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.005]
点击复制

CMR用于评估ACS患者PCI术后心功能改善的研究现状()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年12期
页码:
1078
栏目:
综述
出版日期:
2022-12-25

文章信息/Info

Title:
Research Status of CMR to Evaluate the Improvement of Cardiac Function in ACS Patients after PCI
作者:
耿叶1 孙林 2
(1.昆明医科大学研究生院,云南 昆明 650032;2.昆明医科大学第二附属医院心血管内科,云南 昆明 650032)
Author(s):
GENG Ye1SUN Lin12
?Department of Cardiology,The Second Affiliated Hospital of Kunming Medical UniversityKunming 650032,Yunnan,China)
关键词:
心脏磁共振急性冠脉综合征微血管阻塞心肌内出血心肌延迟强化
Keywords:
Cardiac magnetic resonanceAcute coronary syndromeMicrovascular obstructionIntra myocardial hemorrhageLate gadolinium enhancement
DOI:
10.16806/j.cnki.issn.1004-3934.2022.12.005
摘要:
冠状动脉粥样硬化性心脏病(冠心病)是中国常见的心血管疾病之一,也是导致死亡率升高的主要疾病。经皮冠状动脉介入治疗(PCI)为治疗冠心病的重要方法,经PCI治疗后患者的后续治疗是否需进一步改善一直是临床工作中的重点问题。心脏磁共振成像(CMR)可将心脏结构及功能以图像方式展示出来,具有其独特的一面。现简述利用CMR评估急性冠脉综合征患者行PCI术后心功能改善的研究现状,以期对临床工作提供参考。
Abstract:
Coronary atherosclerotic heart disease(CHD)is one of the common cardiovascular diseases in China and the main disease leading to higher mortality. Percutaneous?coronary?intervention(PCI)is an important method for treating CHD. Whether the follow-up treatment of patients after PCI treatment needs to be further improved has always been a key issue in clinical work. Cardiac magnetic resonance(CMR) can display the structure and function of the heart image,which has its unique characteristics. The article briefly describes the research status of CMR on the improvement of cardiac function in patients undergoing PCI surgery for acute coronary syndrome,in order to provide reference for clinical work.

参考文献/References:

[1]Virani SS,Alonso A,Aparicio HJ,et al. Heart Disease and stroke statistics-2021 update:a report from the American Heart Association[J]. Circulation,2021,143(8):e254-e743.

[2]Canfield J,Totary-Jain H. 40 Years of percutaneous coronary intervention:history and future directions[J]. J Pers Med,2018,8(4):33.

[3]Solomon MD,Leong TK,Levin E,et al. Cumulative adherence to secondary prevention guidelines and mortality after acute myocardial infarction[J]. J Am Heart Assoc,2020,9(6):e014415.

[4]Plakht Y,Gilutz H,Shiyovich A. Excess long-term mortality among hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction(SAMI) project[J]. Public Health,2017,143(Complete):25-36.

[5]中国医师协会胸痛专业委员会,中华心血管病杂志编辑委员会,急性心肌梗死后心室重构防治专家共识起草组. 急性心肌梗死后心室重构防治专家共识[J]. 中华心血管病杂志(网络版),2020,3,(1):1-7.

[6]Chen YD,Fang WY,Chen JY,et al. Chinese expert consensus on the non-invasive imaging examination pathways of stable coronary artery disease[J]. J Geriatr Cardiol,2018,15(1):30-40.

[7]Ismail TF,Strugnell W,Coletti C,et al. Cardiac MR:from theory to practice[J]. Front Cardiovasc Med,2022,9:826283.

[8]刘兵华,王思尧,李莉. 血清巨噬细胞迁移抑制因子与稳定型心绞痛合并高血压患者发生主要不良心血管事件的相关性研究[J]. 中国循证心血管医学杂志,2019,11(4):487-490.

[9]姜波,陈玉成,贺勇. 心脏磁共振成像技术在急性ST段抬高型心肌梗死诊治中的应用价值[J]. 心血管病学进展,2016,37(2):103-107.

[10]Bulluck H,Dharmakumar R,Arai AE,et al. Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction:recent advances,controversies,and future directions[J]. Circulation,2018,137(18):1949-1964.

[11]李东,任雯. 心脏磁共振成像在急性ST段抬高型心肌梗死中的应用新进展[J]. 第二军医大学学报,2019,40(3):233-237.

[12]Bogaert J,Eitel I. Role of cardiovascular magnetic resonance in acute coronary syndrome[J]. Glob Cardiol Sci Pract,2015,2015(2):24.

[13]Ríos-Navarro C,Gavara J,Nú?ez J,et al. EpCAM and microvascular obstruction in patients with STEMI:a cardiac magnetic resonance study[J]. Rev Esp Cardiol (Engl Ed),2022,75(5):384-391.

[14]Symons R,Pontone G,Schwitter J,et al. Long-term incremental prognostic value of cardiovascular magnetic resonance after ST-segment elevation myocardial infarction:a study of the collaborative registry on CMR in STEMI[J]. JACC Cardiovasc Imaging,2018,11(6):813-825.

[15] Niccoli G,Scalone G,Lerman A,et al. Coronary microvascular obstruction in acute myocardial infarction[J]. Eur Heart J,2016,37(13):1024-1033.

[16] Lombardo A,Niccoli G,Natale L,et al. Impact of microvascular obstruction and infarct size on left ventricular remodeling in reperfused myocardial infarction:a contrast-enhanced cardiac magnetic resonance imaging study[J]. Int J Cardiovasc Imaging,2012,28(4):835-842.

[17]van Kranenburg M,Magro M,Thiele H,et al. Prognostic value of microvascular obstruction and infarct size,as measured?by CMR in STEMI patients[J]. JACC Cardiovasc Imaging,2014,7(9):930-939.

[18]de Waha S,Patel MR,Granger CB,et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction:an individual patient data pooled analysis from seven randomized trials[J]. Eur Heart J,2017,38(47):3502-3510.

[19]Carrick D,Haig C,Ahmed N,et al. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction:relation to microvascular obstruction and prognostic significance[J]. Circ Cardiovasc Imaging,2016,9(1):e004148.

[20]Eitel I,de Waha S,W?hrle J,et al. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction[J]. J Am Coll Cardiol,2014,64(12):1217-1226.

[21]Hamirani YS,Wong A,Kramer CM,et al. Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction:a systematic review and meta-analysis[J]. JACC Cardiovasc Imaging,2014,7(9):940-952.

[22]Antiochos P,Ge Y,Heydari B,et al. Prognostic value of stress cardiac magnetic resonance in patients with known coronary artery disease[J]. JACC Cardiovasc Imaging,2022,15(1):60-71.

[23]Domenech-Ximenos B,Sanz-De La Garza M,Prat-González S,et al. Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes[J]. J Cardiovasc Magn Reson,2020,22(1):62.

[24]Qin L,Min J,Chen C,et al. Incremental values of T1 mapping in the prediction of sudden cardiac death risk in hypertrophic cardiomyopathy:a comparison with two guidelines[J]. Front Cardiovasc Med,2021,8:661673.

[25]Agha AM,Palaskas N,Patel AR,et al. Cardiac magnetic resonance predicting outcomes among patients at risk for cardiac AL amyloidosis[J]. Front Cardiovasc Med,2021,8:626414.

[26]Cui Y,Cao Y,Song J,et al. Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation[J]. J Cardiovasc Magn Reson,2018,20(1):25.

[27]Yang S,Du Y,Liu Z,et al. Triglyceride-glucose index and extracellular volume fraction in patients with heart failure[J]. Front Cardiovasc Med,2021,8:704462.

[28]Zhang SJ,Chang D,Jin JY,et al. Myocardial extracellular volume fraction measured by cardiac magnetic resonance imaging negatively correlates with cardiomyocyte breadth in a healthy porcine model[J]. Front Cardiovasc Med,2022,9:791963.

[29]Li S,Zhou D,Sirajuddin A,et al. T1 mapping and extracellular volume fraction in dilated cardiomyopathy:a prognosis study[J]. JACC Cardiovasc Imaging,2022,15(4):578-590.

[30]相里伟,赵世华. MRI评估心肌细胞外容积的现状与进展[J]. 中华放射学杂志,2014,48(11):966-968.

[31]Garg P,Broadbent DA,Swoboda PP,et al. Acute infarct extracellular volume mapping to quantify myocardial area at risk and chronic infarct size on cardiovascular magnetic resonance imaging[J]. Circ Cardiovasc Imaging,2017,10(7):e006182.

[32]Garg P,Broadbent DA,Swoboda PP,et al. Extra-cellular expansion in the normal,non-infarcted myocardium is associated with worsening of regional myocardial function after acute myocardial infarction[J]. J Cardiovasc Magn Reson,2017,19(1):73.

[33]Carrick D,Haig C,Rauhalammi S,et al. Pathophysiology of LV remodeling in?survivors of STEMI:inflammation,remote myocardium,and prognosis[J]. JACC Cardiovasc Imaging,2015,8(7):779-789.

[34]Reinstadler SJ,Stiermaier T,Liebetrau J,et al. Prognostic significance of remote myocardium alterations assessed by quantitative noncontrast T1 mapping in ST-segment elevation myocardial infarction[J]. JACC Cardiovasc Imaging,2018,11(3):411-419.

[35]Collet JP,Thiele H,Barbato E,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J,2021,42(14):1289-1367.

[36]Tessa C,Del Meglio J,Lilli A,et al. T1 and T2 mapping in the identification of acute myocardial injury in patients with NSTEMI[J]. Radiol Med,2018,123(12):926-934.

[37]Smulders MW,Kietselaer BLJH,Wildberger JE,et al. Initial imaging-guided strategy versus routine care in patients with non-ST-segment elevation myocardial infarction[J]. J Am Coll Cardiol,2019,74(20):2466-2477.

[38]Kwong RY,Schussheim AE,Rekhraj S,et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging[J]. Circulation,2003,107(4):531-537.

相似文献/References:

[1]李润土,何泉.光学相干断层成像在急性冠脉综合征介入治疗中的应用[J].心血管病学进展,2019,(6):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
 LI Runtu,HE Quan.Application of Optical Coherent Tomography in Interventional Treatment of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(12):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
[2]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
 GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(12):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
[3]吴洋.左室心肌致密化不全的心脏磁共振诊断[J].心血管病学进展,2019,(5):673.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.004]
 WU Yang.Diagnosis of Left Ventricular Non-compaction Cardiomyopathy With Cardiac Magnetic Resonance Imaging[J].Advances in Cardiovascular Diseases,2019,(12):673.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.004]
[4]徐源蔚 陈玉成.心脏磁共振在检测自身免疫性风湿疾病心脏受累中的应用进展[J].心血管病学进展,2019,(5):676.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.005]
 XU Yuanwei,CHEN Yucheng.Advances in the Application of Cardiac Magnetic Resonance in Detecting Cardiac Involvement in Autoimmune Rheumatic Disease[J].Advances in Cardiovascular Diseases,2019,(12):676.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.005]
[5]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
 GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(12):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[6]冯泽豪 姜萌 卜军.心脏磁共振评价化疗所致心肌损伤的研究进展[J].心血管病学进展,2019,(5):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
 FENG Zehao,JIANG Meng,PU Jun.Cardiovascular Magnetic Resonance for Detection of Myocardial Impairments Caused by Chemotherapy[J].Advances in Cardiovascular Diseases,2019,(12):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
[7]郑晓雪 季福绥.急性冠脉综合征患者发生急性肾损伤的临床进展[J].心血管病学进展,2019,(5):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
 ZHENG Xiaoxue,JI Fusui.Acute Kidney Injury in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(12):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
[8]周小琳 何泉.替格瑞洛在急性冠脉综合征合并慢性肾脏病患者中的应用研究进展[J].心血管病学进展,2019,(5):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
 ZHOU Xiaolin,HE Quan.Ticagrelor in Acute Coronary Syndrome with Chronic Kidney Disease[J].Advances in Cardiovascular Diseases,2019,(12):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
[9]吕俊兴 许海燕.急性冠脉综合征危险评分的研究进展[J].心血管病学进展,2019,(9):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
 LU Junxing,XU Haiyan.Risk Scores of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(12):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
[10]吕颖 胡思宁 于波 贾海波.斑块侵蚀发病机制的最新研究进展[J].心血管病学进展,2020,(1):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]
 LU Ying,HU Sining,YU Bo,et al.Pathogenic Mechanisms of Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(12):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]

更新日期/Last Update: 2023-02-03